VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Prognostic impact of RAS mutations in patients with myelodysplastic syndrome.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Prognostic impact of RAS mutations in patients with myelodysplastic syndrome.
Prognostic impact of RAS mutations in patients with myelodysplastic syndrome. Am J Hematol. 2013 May; 88(5):365-9.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Alleles
Bone Marrow
Cohort Studies
Female
fms-Like Tyrosine Kinase 3
Genetic Association Studies
Humans
Leukocyte Count
Male
Middle Aged
Mutation
Myelodysplastic Syndromes
Prognosis
Proto-Oncogene Proteins p21(ras)
Retrospective Studies
Survival Analysis
authors with profiles
CARLOS E BUESO-RAMOS
HAGOP M KANTARJIAN
RAJYALAKSHMI LUTHRA
ZEEV ESTROV
JORGE E CORTES
FARHAD RAVANDI-KASHANI
GUILLERMO GARCIA-MANERO
ELIAS JOSEPH JABBOUR
GAUTAM BORTHAKUR
TAPAN MAHENDRA KADIA